PATENT CLAIM ANALYSIS

Application Number: 15744216
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising endothelial cells (ECs) differentiated from induced pluripotent stem cells (iPSC)that over-express Sirtuin 1 (SIRT1) are disclosed. Further disclosed are methods of preparation of the compositions, and methods for treating a subject comprising administering transplatanbe cells, tissue, or organ comprising the iPSC-derived ECs overexpressing SIRT1, as well as methods of testing an agent for therapeutic efficacy and toxicity using the compositions.

Claim (Index 12):
The method of  claim 11 , wherein the agent is testing for therapeutic efficacy.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.53061
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14897619', '14884503', '13178239', '14302621', '14138008']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6189075016042529
- 35 USC 102 Novelty (BERT): 0.5059691400152909
- Combined Prediction Score: 0.6076136654453568
- Mean Citation Score: 233.803172
- Max Citation Score: 245.32564
- Similarity Product: 158.86459228629587

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test